<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09811</article-id><article-id pub-id-type="doi">10.7554/eLife.09811</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>FAM150A and FAM150B are activating ligands for Anaplastic Lymphoma Kinase</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-37495"><name><surname>Guan</surname><given-names>Jikui</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37496"><name><surname>Umapathy</surname><given-names>Ganesh</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37497"><name><surname>Yamazaki</surname><given-names>Yasuo</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37498"><name><surname>Wolfstetter</surname><given-names>Georg</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37563"><name><surname>Mendoza</surname><given-names>Patricia</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37500"><name><surname>Pfeifer</surname><given-names>Kathrin</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37501"><name><surname>Mohammed</surname><given-names>Ateequrrahman</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37502"><name><surname>Hugosson</surname><given-names>Fredrik</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37503"><name><surname>Zhang</surname><given-names>Hongbing</given-names></name><aff><institution>Five Prime Therapeutics Inc.</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37504"><name><surname>Hsu</surname><given-names>Amy W</given-names></name><aff><institution>Five Prime Therapeutics Inc.</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37505"><name><surname>Halenbeck</surname><given-names>Robert</given-names></name><aff><institution>Five Prime Therapeutics Inc.</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37506"><name><surname>Hallberg</surname><given-names>Bengt</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-29448"><name><surname>Palmer</surname><given-names>Ruth H</given-names></name><aff><institution content-type="dept">Department of Medical Biochemistry and Cell Biology, Instititute of Biomedicine, Sahlgrenska Academy</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country><email>ruth.palmer@gu.se</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1072"><name><surname>Davis</surname><given-names>Roger</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute &amp; University of Massachusetts Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>09</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e09811</elocation-id><supplementary-material><ext-link xlink:href="elife-09811-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>01</day><month>07</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>09</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Guan et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Guan et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Aberrant activation of Anaplastic Lymphoma Kinase (ALK) has been described in a range of human cancers, including non-small cell lung cancer and neuroblastoma (Hallberg and Palmer 2013). Vertebrate ALK has been considered to be an orphan receptor and the identity of the ALK ligand(s) is a critical issue. Here we show that FAM150A and FAM150B are potent ligands for human ALK that bind to the extracellular domain of ALK and in addition to activation of wild type ALK are able to drive 'superactivation' of activated ALK mutants from neuroblastoma. In conclusion, our data show that ALK is robustly activated by the FAM150A/B ligands and provide an opportunity to develop ALK-targeted therapies in situations where ALK is overexpressed/activated or mutated in the context of the full length receptor.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>